Bluejay Diagnostics (BJDX) Accounts Payables (2020 - 2026)
Bluejay Diagnostics (BJDX) posted Accounts Payables of $220288.0 for Q1 2026, up 2.82% sequentially from $214255.0 in Q4 2025, and down 57.6% YoY from $519524.0 in Q1 2025.
Bluejay Diagnostics (BJDX) Accounts Payables (2020 - 2026) Analysis & Trends
Bluejay Diagnostics has reported Accounts Payables for 7 years, with the latest figure at $220288.0 in Q1 2026.
- Quarterly Accounts Payables fell 57.6% year-over-year to $220288.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $220288.0 (down 57.6% YoY) and the FY2025 annual result came in at $214255.0, up 47.64% from the prior year.
- Accounts Payables grew to $220288.0 in Q1 2026 per BJDX's latest filing, from $214255.0 in the prior quarter.
- Over five years, Accounts Payables peaked at $755949.0 in Q3 2023 and troughed at $108817.0 in Q2 2025.
- A 5-year average of $373320.7 and a median of $316650.0 in 2024 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2022 and 2025: Accounts Payables soared 114.96% in 2022, then plunged 77.79% in 2025.
- Over 5 years, Accounts Payables stood at $635818.0 in 2022, then fell by 22.7% to $491474.0 in 2023, then plunged by 70.47% to $145122.0 in 2024, then surged by 47.64% to $214255.0 in 2025, then advanced by 2.82% to $220288.0 in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $220288.0, $214255.0, and $161162.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 4.79 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 1.66 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 2.64 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 1.23 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 210.50 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 3.23 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 2.42 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 344.10 Mn |
| 10 | Bluejay Diagnostics | 1.89 Mn | 1.89 Mn | - | 674,089.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 674,089.00 |
| Mar 31, 2026 | 220,288.00 |
| Dec 31, 2025 | 214,255.00 |
| Sep 30, 2025 | 161,162.00 |
| Jun 30, 2025 | 108,817.00 |
| Mar 31, 2025 | 519,524.00 |
| Dec 31, 2024 | 145,122.00 |
| Sep 30, 2024 | 316,650.00 |
| Jun 30, 2024 | 490,056.00 |
| Mar 31, 2024 | 271,825.00 |
| Dec 31, 2023 | 491,474.00 |
| Sep 30, 2023 | 755,949.00 |
| Jun 30, 2023 | 271,488.00 |
| Mar 31, 2023 | 388,045.00 |
| Dec 31, 2022 | 635,818.00 |
| Sep 30, 2022 | 443,035.00 |
| Jun 30, 2022 | 196,108.00 |
| Mar 31, 2022 | 716,836.00 |
| Dec 31, 2021 | 295,778.00 |
| Sep 30, 2021 | 242,856.00 |